Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Navigating the way forward to better health outcomes with immunisation
+Practice
In print
Vaccines
Navigating the way forward to better health outcomes with immunisation
Wednesday 14 February 2024, 12:30 AM

The immunisation conference took place at a time of clear skies through which to navigate [Image: Sebastian Knoll on Unsplash]
This article reflects on the key messages from the most recent Aotearoa New Zealand Immunisation Conference
Key actions, Wrap-around health services work best to support communities.
We come in all shapes and sizes – everyone has a right to easy access to vaccines.
“, Pract Green w Pale Yellow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
- Hobbs M, Marek L, Young A, et al. Examining spatial variation for immunisation coverage in pregnant women: A nationwide and geospatial retrospective cohort study in Aotearoa New Zealand. Soc Sci Med 2023;335:116228.
- Montgomerie I, Bird TW, Palmer OR, et al. Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variants. iScience 2023;26(4):106256.
- Njuguna HN, Yusuf N, Raza AA, et al. Progress toward maternal and neonatal tetanus elimination – worldwide, 2000–2018. MMWR Morb Mortal Wkly Rep 2020;69(17):515–20.
- Pankhurst TE, Buick KH, Lange JL, et al. MAIT cells activate dendritic cells to promote TFH cell differentiation and induce humoral immunity. Cell Rep 2023;42(4):112310.
- Phillips A, Jiang Y, Walsh D, et al. Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis. Vaccine 2023;41(42):6227–38.